Update on PharmAust Canine Cancer Trials
Update on PharmAust Canine Cancer Trials
PharmAust’s MPL trials show doubled life expectancy for dogs with cancer
PharmAust’s MPL trials show doubled life expectancy for dogs with cancer (External Link)
PharmAust (ASX:PAA) sees “significant progress” in dog cancer trials
PharmAust (ASX:PAA) sees “significant progress” in dog cancer trials (External Link)